Course Description 
The evolution of gastrointestinal pathology coincident with development of endoscopy and mucosal biopsies has revolutionized management of patients with gastrointestinal disorders. Virtually every part of the tubular gut is now amenable to visualization and sampling. High-resolution cross-sectional imaging routinely detects asymptomatic tumors in patients under surveillance for chronic liver disease. This intensely focused course, presented by a spectacular faculty, will help pathologists generate comprehensive and accurate differential diagnoses for a variety of inflammatory and neoplastic disorders based on limited biopsy material.

Target Audience
Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives
Upon completion of this educational activity, learners will be able to:

• Recognize and classify dysplasia in the setting of Barrett’s esophagus
• Distinguish diagnostic features of medication and pathogen-related intestinal injury in the immunocompromised host
• Formulate a differential diagnosis for sprue-like lesions of the small bowel
• Distinguish invasive adenocarcinoma from mimics in biopsy material
• Classify patterns of hepatic injury

Continuing Medical Education and Maintenance of Certification 
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 15.75  AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The USCAP is approved by the American Board of Pathology (ABP) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABP requirements for Maintenance of Certification (MOC). Registrants must take and pass the post-test in order to claim SAMs credit. Physicians can earn a maximum of 15.25 SAM credit hours.

Disclosures
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships:  Rhonda K. Yantiss, M.D., Joel K. Greenson, M.D., John A. Hart, M.D., Jason L. Hornick, M.D., Ph.D., Laura W. Lamps, M.D., Elizabeth A. Montgomery, M.D.

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.

Evaluated by:  David B. Kaminsky, M.D., FIAC, January 25, 2018
Original release date: March 14, 2018